Welcome to LookChem.com Sign In|Join Free

CAS

  • or

134848-96-7

Post Buying Request

134848-96-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

134848-96-7 Usage

Description

Benzyl 5-Hydroxypentanoate is an organic compound that serves as an intermediate in the synthesis of various biologically active molecules. It is characterized by its unique chemical structure, which allows it to be a key component in the development of pharmaceuticals and other related applications.

Uses

Used in Pharmaceutical Industry:
Benzyl 5-Hydroxypentanoate is used as a synthetic intermediate for the preparation of P2-P1'-linked macrocyclic human renin inhibitors. These inhibitors play a crucial role in the development of medications targeting hypertension and other related conditions by regulating the activity of the human renin enzyme. The compound's ability to be incorporated into complex molecular structures makes it a valuable asset in the design and synthesis of novel therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 134848-96-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,8,4 and 8 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 134848-96:
(8*1)+(7*3)+(6*4)+(5*8)+(4*4)+(3*8)+(2*9)+(1*6)=157
157 % 10 = 7
So 134848-96-7 is a valid CAS Registry Number.

134848-96-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name benzyl 5-hydroxypentanoate

1.2 Other means of identification

Product number -
Other names Pentanoic acid,5-hydroxy-,phenylmethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:134848-96-7 SDS

134848-96-7Relevant articles and documents

Photoswitchable NHC-promoted ring-opening polymerizations

Neilson, Bethany M.,Bielawski, Christopher W.

, p. 5453 - 5455 (2013)

The UV-induced photocyclization of a dithienylethene-annulated N-heterocyclic carbene precatalyst enabled photoswitchable ring-opening polymerizations of ε-caprolactone and δ-valerolactone. The polymerizations proceeded efficiently in ambient light, however UV irradiation attenuated the reaction rate (kamb/kUV = 59). Subsequent visible light exposure reversed the photocyclization and restored catalytic activity.

TAU-PROTEIN TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

-

Paragraph 0992, (2021/02/12)

The present disclosure relates to bifunctional compounds, which find utility as modulators of tan protein. In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a VHL or cereblon ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds tan protein, such that tan protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of tan. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of tan protein. Diseases or disorders that result from aggregation or accumulation of tan protein are treated or prevented with compounds and compositions of the present disclosure.

Modified oligonucleotides and compound that can be used for synthesizing same

-

, (2020/12/08)

The present disclosure falls within the field of biomedical technology, and in particular relates to modified oligonucleatides and a compound that can be used for synthesizing same and a method for modifying oligonucleotides. The present disclosure also relates to the use of the modified oligonucleotides for preventing and/or treating diseases associated with the liver in a subject.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 134848-96-7